BusinessStartup & Funding FDA Approves All Doses of Eli Lilly's Weight-Loss and Diabetes Drugs By Soumyadeep Pal - August 3, 2024 0 Share FacebookTwitterPinterestWhatsAppLinkedinReddItTelegramTumblrDiggFlipNaverEmailPrint GLP-1 therapies, which have seen astronomical growth in demand, have shown to reduce weight by up to 20 percent in trials.